Immuno-Oncology companies

Our unique model combines first access and proprietary rights to disruptive deal flow with an established track record of new venture formation, company buildin…

The Boehringer Ingelheim Venture Fund Mission is to invest in the development of pioneering science – from idea to proof of concept – which offer the potential…